Cancer Archives

News and Trends 22 Jun 2016

What is Microsoft doing with this French Precision Medicine Biotech?

Median Technologies is partnering up with software giant Microsoft to integrate big data into its oncology imaging systems – and deliver Precision Medicine from the cloud. Medical imaging is an important part of the rise of digital medicine. Cool projects in the field include the aortic graft simulation of EVARplanning (one of the startups at Italian incubator […]

June 22, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 22 Jun 2016

World’s first CRISPR Clinical trial has just been Approved!

CRISPR has received a regulatory green light in what could be the first clinical trial with the “scientific discovery of the century”. It’ll be used to improve cancer cell therapies. CRISPR has already revolutionized biotech, quickly overtaking the field of gene editing. It also has immense potential in the therapeutic field, so it’s not surprising there’s a lot […]

June 22, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 20 Jun 2016

Meet the Biotech successfully using Bacteria for Immuno-Oncology

Yes, the title may have surprised you, but it’s true. Vaximm is one of the few biotechs worldwide using bacteria to activate the immune system against cancer. I was really surprised about how elegant the technology is when I had a chat with the Executive Chairman Klaus Breiner at BioEquity in Copenhagen. Vaximm is based in Basel […]

June 20, 2016 - 4 minutesmins - By Philip Hemme

News and Trends 17 Jun 2016

After its drop earlier this year, Genticel goes back up the slope

Genticel has announced that not one but two milestones have been achieved in the development of its products, which focus on immunotherapies for cancers caused by the human papillomavirus. Genticel is developing GTL001 (named ProCervix in Europe) to answer an unmet medical need – the eradication of the virus HPV 16 or 18 (high-risk types that […]

June 17, 2016 - 3 minutesmins - By Jerome Topsent

News and Trends 17 Jun 2016

Apogenix’s lead Candidate has more than one Trick up its Sleeve

Apogenix‘s lead candidate APG101, which has shown great results in a phase II study to treat Glioblastoma, has a new target in line. But this time, it’s not against cancer… Apogenix is a Germany-based company developing innovative immuno-oncology therapeutics for cancer and other malignant diseases. It was founded in 2005 and has raised over €90M […]

June 17, 2016 - 3 minutesmins - By Jerome Topsent

News and Trends 16 Jun 2016

This German Diagnostic company was sold for €50M to the World leading Molecular Diagnostic company

Sividon was a spin-off from Siemens, founded in July 2011 – and it was just sold to the American Myriad Genetics ($2.2Bn market cap) for €50M, even though the company raised only €5M over its lifetime. A clear success story that I discussed with Karlheinz Schmelig, partner of Sividon’s Lead investor Creathor Venture. Sividon worked in […]

June 16, 2016 - 2 minutesmins - By Philip Hemme

News and Trends 10 Jun 2016

Genticel is vaccinating against Cervical Cancer AFTER Infection

Estonia, our previous destination by the Baltic Sea, was a delightful and a full of potential place to visit. This week, we are heading down to the relaxing and sunny south of France, more precisely to Toulouse, once the capital of the Visigothic Kingdom and current to the Midi-Pyrénées region, the largest region in metropolitan France. It […]

June 10, 2016 - 2 minutesmins - By Joachim Eeckhout

News and Trends 9 Jun 2016

How was it inside the ‘World Most Important Cancer Meeting’ of the Year?

Every year by the end of May/beginning of June, up to 30,000 of healthcare professionals head to Chicago to discuss the most recent advancements in Cancer treatments. Here, the MorphoSys team, which included Claudia Gutjahr-Löser and Jochen Orlowski, give you a sneak-insiders look into one of the most essential Cancer conferences of the year… You can also […]

June 9, 2016 - 4 minutesmins - By Dani Bancroft

News and Trends 8 Jun 2016

12 European Biotechs which ‘stole the show’ at World most Important Cancer Meeting

Pharma and Biotech from every corner flocked to Chicago for the beginning of June. Why? It’s where one of the biggest oncology events happens – the ASCO Annual Meeting 2016. Shortly after the AACR annual meeting (with presentations from several European Biotechs), it’s time for the ASCO annual meeting. Hosted by the American Society of Clinical […]

June 8, 2016 - 7 minutesmins - By Denise Neves Gameiro

car t cancer immunooncology biotech labiotech refresh georges rawadi

News and Trends 6 Jun 2016

CAR-T: “This is totally different from what everyone else is doing”

And on the topic of CAR-T, Joachim spoke to Georges Rawadi from the Belgium based biotech, Celyad. Having originally been built on research into a cell therapy for cardiology, Celyad started back in 2007. Now Rawadi explained it’s coming to the end of a cycle for the Cardiology programme. So naturally, they asked what next? Well – […]

June 6, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 3 Jun 2016

Biotech of the Week: High-quality genetic testing with Asper Biotech in Estonia

This week we decided we needed a geographical change and explore slightly different territories… The Baltic sea was a good solution, we thought, so that’s why we are leaving Paris to head up to Tartu, in Estonia, to visit Asper Biotech, our Biotech of the Week. City: Tartu (Estonia) Founded: 1999 Employees: 11 – 50 (as of […]

June 3, 2016 - 2 minutesmins - By Joachim Eeckhout

News and Trends 2 Jun 2016

RNA therapy starts first-of-a-kind trial to treat Liver Cancer

MiNA Therapeutics is launching the first saRNA human trial of its kind – OUTREACH for patients with severe liver cancer. MiNA Therapeutics is a London based RNA specialist, developing RNA activation therapeutics that restore normal function to patients’ cells with an initial focus on severe liver cancer. The study is the first-in-human trial of a small activating RNA […]

June 2, 2016 - 2 minutesmins - By Dani Bancroft

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Cancer

What is Microsoft doing with this French Precision Medicine Biotech?

World’s first CRISPR Clinical trial has just been Approved!

Meet the Biotech successfully using Bacteria for Immuno-Oncology

After its drop earlier this year, Genticel goes back up the slope

Apogenix’s lead Candidate has more than one Trick up its Sleeve

This German Diagnostic company was sold for €50M to the World leading Molecular Diagnostic company

Genticel is vaccinating against Cervical Cancer AFTER Infection

How was it inside the ‘World Most Important Cancer Meeting’ of the Year?

12 European Biotechs which ‘stole the show’ at World most Important Cancer Meeting

CAR-T: “This is totally different from what everyone else is doing”

Biotech of the Week: High-quality genetic testing with Asper Biotech in Estonia

RNA therapy starts first-of-a-kind trial to treat Liver Cancer

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!